HBOC genetic testing subsidies start on 1 December 2026. The Ministry of Health (MOH) said on 5 November 2026 that testing for hereditary breast and ovarian cancer (HBOC) will be subsidised by up to 70% at three public cancer centres, and that MediShield Life now covers risk-reducing surgery for people who test positive.
MOH estimates about 2,000 people a year may benefit from subsidised testing. Here is what changes, and how it is paid for.
What HBOC Is, and Who Is Recommended for Testing
About 1 in 150 Singaporeans carry a gene variant linked to HBOC, according to MOH. Women who carry one have a five- to ten-fold higher lifetime risk of breast or ovarian cancer.
MOH recommends testing for three groups:
- People with breast or ovarian cancer who have risk factors for HBOC.
- First-degree relatives of someone known to carry a variant.
- People with a strong family history of HBOC, where no affected first-degree relative is available to test.
Subsidies apply regardless of gender.
HBOC Genetic Testing Subsidies From 1 December 2026
From 1 December 2026, subsidised testing is offered at the specialist outpatient clinics of the National Cancer Centre Singapore, the National University Cancer Institute, Singapore, and Tan Tock Seng Hospital.
- Subsidies are means-tested, up to 70%, for Singapore Citizens and Permanent Residents. Pioneer and Merdeka Generation seniors receive more.
- MediSave can pay the rest. Until the new limits start in January 2027, the existing chronic and preventive care limits of $500 and $700 a year are extended to cover the test.
- Flexi-MediSave can be used by those aged 60 and above for remaining costs.
| Test | Indicative price before subsidy | After subsidies and MediSave, MOH example |
|---|---|---|
| First patient tested (index) | About $1,000 | $0 |
| Relative tested (cascade) | About $550 | $0 |
Prices include the test, counselling before and after, and the blood draw. MOH says the $0 applies to people with sufficient MediSave balances.
The short version: From 1 December 2026, testing for HBOC gene variants is subsidised by up to 70% at three public cancer centres, and MOH’s examples show $0 to pay after MediSave for those with enough in their account. MediShield Life already covers risk-reducing mastectomy for carriers.
What MediShield Life and MediSave Now Cover After a Positive Test
Risk-reducing surgery. MediShield Life covers risk-reducing mastectomy for patients who test positive and choose the surgery, and MOH says this has applied since 28 September 2026. For example, a simple mastectomy has a MediShield Life claim limit of $2,310 and a MediSave withdrawal limit of $2,380. Cover for risk-reducing removal of the ovaries and fallopian tubes is due by the end of 2026.
Surveillance. Regular scans such as MRI and mammograms can be paid under MediSave’s outpatient scans limit, which MOH says was doubled to $600 a year in 2026, and under Flexi-MediSave for those aged 60 and above.
Higher MediSave limits from 1 January 2027. The yearly MediSave limit for chronic and preventive care rises from $500 to $700, and from $700 to $1,000 for complex chronic conditions.
MediShield Life’s usual deductible and co-insurance still apply to surgery claims. Our explainer on how a hospital bill is paid walks through how those work.
What It Means for Your Insurance
MOH’s release does not mention Integrated Shield Plans. If you hold one, ask your insurer how it treats risk-reducing surgery and genetic counselling under your plan. Our MediShield Life vs Integrated Shield Plan guide explains how the two layers share a claim.
For private critical illness or cancer policies, check the policy wording and any questions about genetic test results before you apply or renew. Our critical illness insurance guide explains how those policies define a claim.
What To Do Next
- If you have a family history of breast or ovarian cancer, ask your doctor whether a referral for HBOC testing is appropriate.
- Check your MediSave balance and what MediSave can be used for.
- Read MOH’s release for the full eligibility criteria and the list of covered procedures.
